fda warns semaglutide Gives Ozempic New Side Effect Warning prorx semaglutide FDA issues warning

A similar signal also appeared in Lillys Phase 3 diabetes program for retatrutide, though at lower rates

The higher dose is typically used for people who are being treated for obesity

By contrast, we only exist because of our community, and we are dedicated to supporting it

We are running operations 24/7, building new lines and facilities, and procuring and building new capacity and plants. Eli Lilly, which produces Mounjaro (tirzepatide), is also expecting shortages of the drug throughout early 2024

They reduce cardiovascular risk factors including high blood pressure and cholesterol levels

At the same time, insurers are pushing back on coverage due to high costs and limited long-term data, creating significant access challenges for patients